Genenta Science S.p.A. (GNTA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-115.9%

-$0.13

vs $0.82 price

Levered DCF

-$0.12

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-1.71

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-3.84×	-8.57×	-7×	-10.93×	-31.09×	-29.03×	-39.23×
P/B	1.14×	6.14×	3.99×	3×	4.52×	10.76×	9.43×
P/S	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	-4.62×	-7.79×	-6.83×	-7.71×	-24.02×	-28.39×	-34.57×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	14.16×	6.89×	12.25×	14.53×	34.15×	7.09×	8.29×
Debt / equity	0.35×	0×	0×	0×	0×	0×	0×
Interest coverage	-16.51×	0×	0×	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-28.7%	-74.5%	-56.0%	-26.6%	-14.8%	-34.3%	-24.0%
Return on invested capital	-21.3%	-80.1%	-55.9%	-34.5%	-15.2%	-34.3%	-24.2%
Return on assets	-19.7%	-62.8%	-51.2%	-24.8%	-14.4%	-29.7%	-21.2%
Free cash flow yield	-27.5%	-8.1%	-13.8%	-8.0%	-4.0%	-3.7%	-1.4%
Earnings yield	-25.1%	-12.1%	-14.0%	-8.8%	-3.3%	-3.2%	-2.6%
Enterprise value	$27.1M	$72.2M	$77.9M	$63.8M	$138.3M	$147.6M	$157.6M
Net debt / EBITDA	-0.35×	0.49×	0.32×	3.6×	6.47×	2.97×	4.42×
Cash conversion cycle (days)	-20,423	-2,494	-2,582	-63,878	-8,137	-108,869	0